On Friday, Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), subtract -1.35% and shut at $8.75 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $8.58 and $8.96 . Amicus Therapeutics (FOLD), a global biotechnology company at the forefront of rare and orphan diseases, recently declared that data from the pivotal Phase 3 Study 012 (ATTRACT) evaluating the efficacy and safety of the oral pharmacological chaperone migalastat contrast with Enzyme Replacement Therapy (ERT) in individuals with Fabry disease were published online in the Journal of Medical Genetics1.
“We are honored that the Journal of Medical Genetics has published our pivotal Phase 3 ATTRACT study in patients with Fabry disease who were switched from ERT to migalastat,” said Jay Barth, MD, Chief Medical Officer of Amicus Therapeutics, Inc. “We believe that this 18-month, randomized, active-controlled study generated a strong clinical data set for our precision medicine migalastat. This Phase 3 study, together with our Phase 3 Study 011 in Fabry patients who were naïve to treatment, supported the European Commission’s full approval for migalastat in the European Union as a first line therapy for Fabry disease in patients 16 years and older who have an amfacilitate genetic mutation. This publication is a major accomplishment, and I would like to thank the physicians who were investigators in this study, in addition to the patients and families who take partd in the study.”
Shares of Franklin Resources, Inc. (NYSE:BEN), added 0.13 % and shut at $38.89 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $38.70 and $39.17. The association’s commercial center capitalization is $22.15 Billion with the general uncommon loads of 568.81 million. Franklin Universal Trust ( NYSE : FT ), a closed-end investment company managed by Franklin Advisers, Inc., declared recently a dividend of $0.032 per share, payable December 15, 2016, to shareholders of record on November 30, 2016 (Ex-Dividend Date: November 28, 2016).=
Dividends may vary based on the Fund’s net investment income. Past dividends are not indicative of future trends.